LIMN
Liminatus Pharma Inc.

1,714
Mkt Cap
$11.68M
Volume
98,291.00
52W High
$33.66
52W Low
$0.3505
PE Ratio
-2.03
LIMN Fundamentals
Price
$0.2562
Prev Close
$0.376
Open
$0.2533
50D MA
$0.8268
Beta
1.05
Avg. Volume
125,934.65
EPS (Annual)
-$0.4038
P/B
-6.18
Rev/Employee
$0.00
$85.01
Loading...
Loading...

About

Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Liminatus Pharma Inc. - Ordinary Shares - Class A?
What is the 52-week high for Liminatus Pharma Inc. - Ordinary Shares - Class A?
What is the 52-week low for Liminatus Pharma Inc. - Ordinary Shares - Class A?
What is Liminatus Pharma Inc. - Ordinary Shares - Class A stock price today?
What was Liminatus Pharma Inc. - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Liminatus Pharma Inc. - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Liminatus Pharma Inc. - Ordinary Shares - Class A?
What is the 50-day moving average of Liminatus Pharma Inc. - Ordinary Shares - Class A?
How many employees does Liminatus Pharma Inc. - Ordinary Shares - Class A have?

Latest LIMN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.